Xvivo Perfusion AB (publ) (FRA:3XV)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	673	543	1,344	934	490	799
Market Cap Growth	-48.22%	-59.60%	43.98%	90.53%	-38.66%	-11.00%
Enterprise Value	657	529	1,307	883	462	772
Last Close Price	22.20	17.08	42.15	-	-	-
PE Ratio	289.60	233.59	89.46	113.04	296.26	1007.78
PS Ratio	8.97	7.24	18.73	17.37	13.15	31.80
PB Ratio	3.45	2.78	7.14	5.34	3.82	6.39
P/TBV Ratio	4.98	4.01	10.81	7.84	6.86	10.06
P/FCF Ratio	-	58.16	379.77	3172.09	564.50	-
P/OCF Ratio	72.10	58.16	138.41	224.23	195.98	-
EV/Sales Ratio	8.53	7.05	18.21	16.42	12.40	30.71
EV/EBITDA Ratio	50.01	41.32	135.06	515.41	387.15	-
EV/EBIT Ratio	78.37	64.75	167.53	1818.08	1156.32	-
EV/FCF Ratio	-	56.62	369.29	2998.27	532.54	-
Debt / Equity Ratio	0.06	0.06	0.02	0.02	0.01	0.00
Debt / EBITDA Ratio	0.90	0.90	0.28	1.06	0.51	-
Debt / FCF Ratio	1.23	1.23	0.84	9.61	1.03	-
Asset Turnover	0.34	0.34	0.36	0.30	0.25	0.19
Inventory Turnover	0.89	0.89	1.12	1.23	1.29	1.02
Quick Ratio	3.68	3.68	3.14	4.94	2.60	4.43
Current Ratio	5.77	5.77	4.58	6.15	3.47	5.24
Return on Equity (ROE)	1.18%	1.18%	8.39%	5.44%	1.36%	0.71%
Return on Assets (ROA)	2.31%	2.31%	2.43%	0.17%	0.17%	-0.87%
Return on Invested Capital (ROIC)	2.97%	3.10%	4.80%	0.40%	0.35%	-2.41%
Return on Capital Employed (ROCE)	3.90%	3.90%	4.00%	0.30%	0.30%	-1.30%
Earnings Yield	0.35%	0.43%	1.12%	0.89%	0.34%	0.10%
FCF Yield	-	1.72%	0.26%	0.03%	0.18%	-0.27%
Buyback Yield / Dilution	0.29%	0.29%	-5.73%	-1.39%	-2.04%	-6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.